A carregar...
The B-cell receptor signaling pathway as a therapeutic target in CLL
Targeted therapy with imatinib and other selective tyrosine kinase inhibitors has transformed the treatment of chronic myeloid leukemia. Unlike chronic myeloid leukemia, chronic lymphocytic leukemia (CLL) lacks a common genetic aberration amenable to therapeutic targeting. However, our understanding...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3418714/ https://ncbi.nlm.nih.gov/pubmed/22715122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-362624 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|